Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis

Kamonpun Ussavarungsi, Xiaowen Hu, J. P. Scott, David B. Erasmus, Jorge M. Mallea, Francisco Alvarez, Augustine S. Lee, Cesar A. Keller, Jay H Ryu, Charles Dwayne Burger

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Objectives Lymphangioleiomyomatosis (LAM) is a rare, cystic lung disease that generally results in progressive decline in lung function. Despite advancement of pharmacological therapy for LAM, lung transplantation remains an important option for women with end-stage LAM. Methods Patients with LAM undergoing lung transplantation at the Mayo Clinic campuses in Rochester, Minnesota and Jacksonville, Florida since 1995 were retrospectively reviewed. Results Overall, 12 women underwent lung transplantation. Nine of 12 (75%) underwent double lung transplant. The mean age was 42 ± 8 years at the time of transplant. One patient (8%) had a chylothorax and 7 (58%) had recurrent pneumothoraces, 4 (33%) of which required pleurodesis. All had diffuse, cystic lung disease on chest CT consistent with LAM which was confirmed in the explant of all patients. The average length of ICU and hospital stays were 5 ± 4 and 19 ± 19 days, respectively. Mild to moderate anastomotic ischemia was evident in all patients but resolved with time. No patient was treated with sirolimus pre-transplant. Seven patients received sirolimus post-transplant; however, clinical benefit was documented in only 2 patients, 1 of which was treated for large retroperitoneal cysts with ureteral obstruction and another with persistent chylothorax and retroperitoneal lymphangioleimyomas. Five patients are deceased. The median survival by Kaplan-Meier analysis was 119 months with a median follow-up of 68 months (range 2-225 months). Conclusions Lung transplant remains a viable treatment for patients with end-stage LAM. The role of sirolimus peri-transplantation remains ill-defined.

Original languageEnglish (US)
Pages (from-to)1354-1359
Number of pages6
JournalRespiratory Medicine
Volume109
Issue number10
DOIs
StatePublished - Oct 1 2015

Keywords

  • Lung transplantation
  • Lymphangioleiomyomatosis
  • Outcome
  • Sirolimus

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis'. Together they form a unique fingerprint.

  • Cite this

    Ussavarungsi, K., Hu, X., Scott, J. P., Erasmus, D. B., Mallea, J. M., Alvarez, F., Lee, A. S., Keller, C. A., Ryu, J. H., & Burger, C. D. (2015). Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis. Respiratory Medicine, 109(10), 1354-1359. https://doi.org/10.1016/j.rmed.2015.08.014